The Whittington Hospital NHS Trust RKE Lung Cancer Clinical

 The Whittington Hospital NHS Trust RKE  London Cancer Strategic Clinical Network Lung Cancer Clinical Outcomes Publication 2017 (2015 data)

The fourth Lung Cancer Clinical Outcomes Publication reports the outcomes of operations to remove lung cancer for patients in English NHS hospitals during the 2015 calendar year. 28 NHS Trusts provided lung cancer surgery in 2015, and the 27 units still active have validated their activity for this period. The full report is available at www.rcplondon.ac.uk/nlca and also on NHS Choices to help patients make decisions about their treatment. This short report gives results for the local surgical services. The surgical centre(s) that carry out surgery on your patients are highlighted yellow. Data for this report is based on patient-level information collected by the NHS, as part of the care and support of cancer patients. The data is collated, maintained and quality assured by the National Cancer Registration and Analysis Service, which is part of Public Health England (PHE). Validation of local data, and collection of data on surgical approach, has been performed in collaboration with the Society for Cardiothoracic Surgery (SCTS) and their network of local audit leads. "Tertiary” denotes a tertiary trust. These provide treatment for lung cancer patients, but where patients are not usually first seen. The cases may have been incorrectly allocated to this trust, and instead first seen at another trust in the region. The data should be interpreted with caution.

Your surgical units Surgical cases 30d survival 90d survival 1yr survival 1 LOS 2

Barts Health NHS Trust 148 98.7% 97.1% 89.6% 8 days

University College London Hospitals NHS FT 179 98.4% 97.0% 85.2% 7 days

England 5,843 97.9% 96.2% 87.9% 6 days

 Overall resection rates for trusts in this network (2015)

All lung cancer Resection rate all lung cancer Resection rate stage 1/2 NSCLC Trust cases 3 4

Barts Health NHS Trust 411 17.5%  60.4%

Royal Free London NHS FT 314 14.3%  55.2%

North Middlesex University Hospital NHS Trust 126 6.3%  35.7%

Barking, Havering and Redbridge Univ. Hospitals NHS 364 14.6%  69.0% Trust

The Whittington Hospital NHS Trust 64 26.6%  77.3%

The Princess Alexandra Hospital NHS Trust 170 15.9%  57.1%

Homerton University Hospital NHS FT 91 18.7%  68.0%

University College London Hospitals NHS FT 198 36.4%  73.3%

England 36,025 16.0% 51.7%

 Not statistically significant ||  Significantly better ||  Significantly worse (all at 95% confidence level 5)

 30-day survival 6

102 UNIVERSITY COLLEGE LONDON HOSPITALS NHS FT 100 98.4% +0.3  98  This result is not statistically significant at the 99.8% level 7. 96

90 50 100 150 200 250 300 350 400 450 500

 90-day survival 6

102.5 UNIVERSITY COLLEGE LONDON HOSPITALS NHS FT 100.0 97.0% +0.6  97.5  This result is not statistically significant at the 99.8% level 7. 95.0

92.5

90.0

87.5 50 100 150 200 250 300 350 400 450 500

 1-year survival 6

105 UNIVERSITY COLLEGE LONDON HOSPITALS NHS FT 100 Not measured in previous year 95 85.2%

90  This result is not statistically significant at the 99.8% level 7.

70 50 100 150 200 250 300 350 400 450 500

1 Although one year survival rates after surgery are important and of interest to patients, we advise caution in using this metric as a direct measure of the quality of surgical care. Many factors outside the control of surgical teams are very likely to affect 1-year survival. This metric should not be used in isolation, but could help to direct future local audit or quality improvement activity by the wider lung cancer team :: 2 Length of stay :: 3 The proportion of all patients with lung cancer that receive surgery as part of their lung cancer treatment :: 4 The proportion of patients with early stage disease that receive surgery as part of their lung cancer treatment :: 5 Less than 5 in 100 chance that the results are due to chance :: 6 Survival data are adjusted for age, gender, laterality (side of surgery), performance status, socio-economic status, cancer stage, FEV1 and co-morbidity :: 7 Less than 2 in 1000 chance that the results are due to chance  The Whittington Hospital NHS Trust RKE  London Cancer Strategic Clinical Network Lung Cancer Clinical Outcomes Publication 2017 (2015 data)